RPRX

Royalty Pharma Plc Class A · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website royaltypharma.com
Employees(FY) -
ISIN GB00BMVP7Y09

Performance

+1.67%

-5.52%

-3.84%

-2.32%

-3.78%

YTD

+0.36%

Profile

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.

Advanced Technical Analysis

Technical Analysis of RPRX 2024-11-20

The stock indicators reflect a mixed sentiment, with the Moving Average Score at 30 indicating a bearish outlook, while the Oscillators Score of 53 suggests a neutral stance, and the overall Technical Score of 41 reinforces a bearish sentiment. This combination implies caution, as the prevailing indicators do not signal strong bullish momentum.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of RPRX

Stock Rank

Recent News & Updates

2024-11-14 16:30
Royalty Pharma Announces Inaugural Prize for Impact in Healthcare(GlobeNewswire)
2024-11-14 03:30
Royalty Pharma Announces Inaugural Prize for Impact in Healthcare(Globenewswire)
2024-11-13 06:59
Royalty Pharma's (NASDAQ:RPRX) Profits May Not Reveal Underlying Issues(Simply Wall St.)
2024-11-07 07:10
Royalty Pharma to Acquire Royalty Interest in Geron’s RYTELO for $125 Million(GlobeNewswire)
2024-11-07 02:10
Royalty Pharma PLC (RPRX) Q3 2024 Earnings Call Highlights: Strong Growth and Strategic Acquisitions(GuruFocus.com)
2024-11-07 00:08
Royalty Pharma PLC (RPRX): A Strategic SWOT Insight(GuruFocus.com)
2024-11-06 19:16
Analyst Report: Royalty Pharma plc(Morningstar Research)
2024-11-06 18:10
Royalty Pharma to Acquire Royalty Interest in Geron's RYTELO for $125 Million(Globenewswire)
2024-11-06 07:15
Royalty Pharma Reports Third Quarter 2024 Results(GlobeNewswire)
2024-11-05 18:15
Royalty Pharma Reports Third Quarter 2024 Results(Globenewswire)
2024-11-04 16:15
Royalty Pharma and Syndax Pharmaceuticals Enter Into $350 Million Royalty Funding Agreement for Niktimvo(GlobeNewswire)
2024-11-04 16:01
Syndax Pharmaceuticals and Royalty Pharma Enter into $350 Million Royalty Funding Agreement for Niktimvo™(PR Newswire)
2024-11-04 03:15
Royalty Pharma and Syndax Pharmaceuticals Enter Into $350 Million Royalty Funding Agreement for Niktimvo(Globenewswire)
2024-11-04 03:01
Syndax Pharmaceuticals and Royalty Pharma Enter into $350 Million Royalty Funding Agreement for Niktimvo(Prnewswire)
2024-11-03 06:11
Morgan Stanley Predicts Up to 670% Jump for These 2 ‘Strong Buy’ Stocks(TipRanks)
2024-10-16 16:15
Royalty Pharma to Announce Third Quarter 2024 Financial Results on November 6, 2024(GlobeNewswire)
2024-10-16 04:15
Royalty Pharma to Announce Third Quarter 2024 Financial Results on November 6, 2024(Globenewswire)
2024-10-14 06:33
Royalty Pharma's (NASDAQ:RPRX) Dividend Will Be $0.21(Simply Wall St.)
2024-10-11 08:15
Royalty Pharma Declares Fourth Quarter 2024 Dividend(GlobeNewswire)
2024-10-10 20:15
Royalty Pharma Declares Fourth Quarter 2024 Dividend(Globenewswire)
2024-10-09 17:31
Royalty Pharma PLC (RPRX) Q2 2024 Earnings Call Highlights: Surpassing Growth Expectations and ...(GuruFocus.com)
2024-10-09 15:50
Royalty Pharma plc (RPRX): Among The Stocks With Biggest Upside Potential According to Hedge Funds(Insider Monkey)
2024-09-06 09:34
Royalty Pharma plc's (NASDAQ:RPRX) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?(Simply Wall St.)
2024-09-03 17:14
Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement(GlobeNewswire)
2024-09-03 17:06
Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement(GlobeNewswire)
2024-09-03 05:14
Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement(Globenewswire)
2024-09-03 05:06
Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement(Globenewswire)
2024-08-28 16:15
Royalty Pharma to Present at Morgan Stanley’s 22nd Annual Global Healthcare Conference(GlobeNewswire)
2024-08-28 04:15
Royalty Pharma to Present at Morgan Stanley's 22nd Annual Global Healthcare Conference(Globenewswire)
2024-08-26 06:16
Jim Cramer on Royalty Pharma plc (NASDAQ:RPRX): It’s Been a ‘Bit of a Bust, I Feel Badly’(Insider Monkey)

Page 1 of 8

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.